Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Microbial-derived TMAO Production From Carnitine Intake by Testing Fecal Gbu Gene

NCT05980884 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT05980884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05980884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Microbial-derived TMAO Production From Carnitine Intake by Testing Fecal Gbu Gene
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 24, 2023
Completion date
July 30, 2026
Enrollment
230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gut dysbiosis for tmao production from l-carnitine consumption